Concepts (224)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hepatitis A | 11 | 2016 | 126 | 3.070 |
Why?
|
| Population Surveillance | 20 | 2016 | 2590 | 1.460 |
Why?
|
| Cross Infection | 13 | 2013 | 1427 | 1.400 |
Why?
|
| Hepatitis C | 11 | 2016 | 1597 | 1.330 |
Why?
|
| Methicillin Resistance | 4 | 2007 | 198 | 1.000 |
Why?
|
| Hepatitis A Vaccines | 3 | 2016 | 26 | 0.990 |
Why?
|
| Hepatitis A Antibodies | 2 | 2015 | 19 | 0.890 |
Why?
|
| Hepatitis A virus | 2 | 2015 | 16 | 0.870 |
Why?
|
| Staphylococcal Infections | 6 | 2008 | 1393 | 0.790 |
Why?
|
| Hepatitis B | 7 | 2015 | 707 | 0.730 |
Why?
|
| Immunization Programs | 7 | 2016 | 267 | 0.680 |
Why?
|
| Staphylococcus aureus | 4 | 2007 | 1424 | 0.600 |
Why?
|
| Substance Abuse, Intravenous | 4 | 2020 | 531 | 0.600 |
Why?
|
| Health Knowledge, Attitudes, Practice | 4 | 2018 | 4058 | 0.500 |
Why?
|
| Hepatitis B, Chronic | 3 | 2015 | 412 | 0.500 |
Why?
|
| Homosexuality, Male | 4 | 2021 | 1342 | 0.470 |
Why?
|
| Hepacivirus | 5 | 2016 | 1343 | 0.430 |
Why?
|
| Risk-Taking | 5 | 2019 | 1021 | 0.390 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 2 | 2009 | 705 | 0.390 |
Why?
|
| United States | 44 | 2016 | 72903 | 0.380 |
Why?
|
| Bacteremia | 3 | 2008 | 989 | 0.380 |
Why?
|
| HIV Infections | 11 | 2024 | 17533 | 0.340 |
Why?
|
| Hepatitis C, Chronic | 5 | 2016 | 1032 | 0.320 |
Why?
|
| Community-Acquired Infections | 3 | 2008 | 470 | 0.310 |
Why?
|
| Travel | 1 | 2015 | 806 | 0.310 |
Why?
|
| Acquired Immunodeficiency Syndrome | 4 | 2016 | 2203 | 0.310 |
Why?
|
| Catheters, Indwelling | 2 | 2008 | 438 | 0.300 |
Why?
|
| Staphylococcal Skin Infections | 1 | 2009 | 77 | 0.300 |
Why?
|
| Anti-Retroviral Agents | 1 | 2018 | 1787 | 0.300 |
Why?
|
| Emigrants and Immigrants | 1 | 2015 | 549 | 0.300 |
Why?
|
| Health Care Surveys | 5 | 2014 | 2424 | 0.290 |
Why?
|
| Vaccination | 7 | 2022 | 3426 | 0.280 |
Why?
|
| Renal Dialysis | 2 | 2008 | 1799 | 0.270 |
Why?
|
| Cost of Illness | 1 | 2016 | 1950 | 0.260 |
Why?
|
| Liver Cirrhosis | 1 | 2016 | 1959 | 0.250 |
Why?
|
| Age Distribution | 5 | 2015 | 2858 | 0.250 |
Why?
|
| Pneumonia, Bacterial | 1 | 2008 | 318 | 0.250 |
Why?
|
| Smallpox Vaccine | 1 | 2005 | 77 | 0.240 |
Why?
|
| Ambulatory Care | 3 | 2014 | 2778 | 0.230 |
Why?
|
| Escherichia coli Infections | 1 | 2008 | 519 | 0.230 |
Why?
|
| Catheterization, Central Venous | 2 | 2007 | 539 | 0.230 |
Why?
|
| Pseudomonas Infections | 1 | 2008 | 622 | 0.220 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2018 | 3230 | 0.220 |
Why?
|
| Sentinel Surveillance | 1 | 2006 | 293 | 0.220 |
Why?
|
| DNA, Viral | 1 | 2010 | 2199 | 0.220 |
Why?
|
| Adolescent | 21 | 2020 | 88835 | 0.220 |
Why?
|
| HIV | 2 | 2012 | 1585 | 0.220 |
Why?
|
| Iatrogenic Disease | 1 | 2007 | 553 | 0.220 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2004 | 355 | 0.210 |
Why?
|
| Sex Distribution | 4 | 2015 | 2263 | 0.210 |
Why?
|
| Intensive Care Units | 2 | 2006 | 3800 | 0.200 |
Why?
|
| Urinary Tract Infections | 1 | 2008 | 805 | 0.200 |
Why?
|
| Seroepidemiologic Studies | 2 | 2015 | 404 | 0.200 |
Why?
|
| Infection Control, Dental | 2 | 2013 | 8 | 0.190 |
Why?
|
| Preventive Health Services | 1 | 2006 | 570 | 0.180 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2008 | 1069 | 0.180 |
Why?
|
| Dentists | 1 | 2022 | 176 | 0.180 |
Why?
|
| Directly Observed Therapy | 1 | 2021 | 139 | 0.170 |
Why?
|
| Young Adult | 16 | 2020 | 59889 | 0.170 |
Why?
|
| Epidemiologic Methods | 2 | 2016 | 1326 | 0.170 |
Why?
|
| Adult | 32 | 2024 | 223044 | 0.170 |
Why?
|
| Chlamydia Infections | 2 | 2021 | 364 | 0.170 |
Why?
|
| Humans | 65 | 2024 | 765968 | 0.170 |
Why?
|
| Nutrition Surveys | 4 | 2016 | 1741 | 0.160 |
Why?
|
| Child, Preschool | 14 | 2016 | 42500 | 0.160 |
Why?
|
| Pneumococcal Infections | 1 | 2024 | 527 | 0.160 |
Why?
|
| Pharmacies | 1 | 2021 | 171 | 0.150 |
Why?
|
| Terminology as Topic | 1 | 2005 | 1534 | 0.150 |
Why?
|
| Middle Aged | 27 | 2024 | 223009 | 0.150 |
Why?
|
| Infection Control | 1 | 2005 | 983 | 0.150 |
Why?
|
| Male | 35 | 2024 | 363698 | 0.140 |
Why?
|
| Condoms | 1 | 2019 | 336 | 0.140 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 2 | 2007 | 142 | 0.140 |
Why?
|
| Immunization Schedule | 3 | 2016 | 228 | 0.140 |
Why?
|
| Infant | 12 | 2024 | 36386 | 0.130 |
Why?
|
| Antimalarials | 1 | 2023 | 913 | 0.130 |
Why?
|
| Child | 14 | 2024 | 80564 | 0.130 |
Why?
|
| Female | 33 | 2024 | 396112 | 0.120 |
Why?
|
| Sexual Behavior | 3 | 2021 | 2193 | 0.120 |
Why?
|
| Hepatitis C Antibodies | 2 | 2014 | 151 | 0.120 |
Why?
|
| Rheumatic Diseases | 1 | 2022 | 622 | 0.120 |
Why?
|
| Vaccines | 1 | 2004 | 841 | 0.120 |
Why?
|
| Viral Load | 1 | 2024 | 3386 | 0.120 |
Why?
|
| Uridine Monophosphate | 1 | 2015 | 67 | 0.120 |
Why?
|
| Attitude of Health Personnel | 1 | 2009 | 3925 | 0.120 |
Why?
|
| Urban Population | 3 | 2019 | 2040 | 0.110 |
Why?
|
| Risk Factors | 14 | 2020 | 74840 | 0.110 |
Why?
|
| Behavioral Risk Factor Surveillance System | 1 | 2015 | 212 | 0.110 |
Why?
|
| Universal Precautions | 1 | 2013 | 34 | 0.110 |
Why?
|
| Hepatitis, Viral, Human | 1 | 2014 | 141 | 0.110 |
Why?
|
| Hepatitis B virus | 2 | 2015 | 530 | 0.100 |
Why?
|
| Internet | 1 | 2005 | 3106 | 0.100 |
Why?
|
| Social Stigma | 1 | 2019 | 788 | 0.100 |
Why?
|
| Hospital Mortality | 1 | 2007 | 5343 | 0.100 |
Why?
|
| Cities | 1 | 2015 | 543 | 0.100 |
Why?
|
| Body Piercing | 1 | 2012 | 9 | 0.100 |
Why?
|
| National Health Programs | 5 | 2004 | 443 | 0.100 |
Why?
|
| Antirheumatic Agents | 1 | 2022 | 1365 | 0.100 |
Why?
|
| Hepatitis B Vaccines | 1 | 2013 | 178 | 0.100 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2018 | 667 | 0.100 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2015 | 390 | 0.100 |
Why?
|
| Health Surveys | 3 | 2013 | 4056 | 0.100 |
Why?
|
| Aged | 17 | 2018 | 171117 | 0.090 |
Why?
|
| Health Personnel | 1 | 2005 | 3390 | 0.090 |
Why?
|
| Incidence | 6 | 2024 | 21480 | 0.090 |
Why?
|
| Anti-Bacterial Agents | 3 | 2022 | 7478 | 0.090 |
Why?
|
| Age Factors | 4 | 2020 | 18380 | 0.090 |
Why?
|
| Dental Care | 1 | 2013 | 286 | 0.090 |
Why?
|
| Acute Disease | 4 | 2014 | 7232 | 0.090 |
Why?
|
| Knowledge | 1 | 2012 | 178 | 0.090 |
Why?
|
| International Classification of Diseases | 2 | 2014 | 935 | 0.090 |
Why?
|
| Disease Notification | 2 | 2012 | 95 | 0.090 |
Why?
|
| Mexican Americans | 1 | 2011 | 165 | 0.090 |
Why?
|
| Communicable Disease Control | 1 | 2016 | 856 | 0.080 |
Why?
|
| Poverty | 2 | 2001 | 2714 | 0.080 |
Why?
|
| Socioeconomic Factors | 7 | 2022 | 7838 | 0.080 |
Why?
|
| Prevalence | 6 | 2020 | 15842 | 0.080 |
Why?
|
| Blood | 1 | 2012 | 597 | 0.080 |
Why?
|
| Databases, Factual | 1 | 2005 | 8067 | 0.080 |
Why?
|
| Medical Informatics | 1 | 2016 | 745 | 0.080 |
Why?
|
| Continuity of Patient Care | 1 | 2016 | 1078 | 0.080 |
Why?
|
| Program Evaluation | 3 | 2016 | 2499 | 0.080 |
Why?
|
| End Stage Liver Disease | 1 | 2014 | 369 | 0.080 |
Why?
|
| Cephalexin | 1 | 2009 | 37 | 0.080 |
Why?
|
| Equipment Contamination | 2 | 2013 | 183 | 0.080 |
Why?
|
| Boston | 2 | 2019 | 9338 | 0.080 |
Why?
|
| Molecular Epidemiology | 1 | 2010 | 471 | 0.080 |
Why?
|
| Antiviral Agents | 2 | 2023 | 3050 | 0.070 |
Why?
|
| Infant, Newborn | 4 | 2016 | 26346 | 0.070 |
Why?
|
| Mass Screening | 2 | 2013 | 5446 | 0.070 |
Why?
|
| Massachusetts | 4 | 2024 | 8875 | 0.070 |
Why?
|
| Adolescent Behavior | 1 | 2015 | 1185 | 0.070 |
Why?
|
| Blood-Borne Pathogens | 1 | 2006 | 51 | 0.060 |
Why?
|
| Cause of Death | 2 | 2013 | 3708 | 0.060 |
Why?
|
| Information Storage and Retrieval | 1 | 2011 | 834 | 0.060 |
Why?
|
| Homosexuality | 1 | 2006 | 267 | 0.060 |
Why?
|
| Alcoholism | 1 | 2016 | 1975 | 0.060 |
Why?
|
| Substance-Related Disorders | 2 | 2019 | 4416 | 0.060 |
Why?
|
| Sampling Studies | 1 | 2006 | 607 | 0.060 |
Why?
|
| Time | 1 | 2006 | 550 | 0.060 |
Why?
|
| Heterosexuality | 1 | 2006 | 308 | 0.060 |
Why?
|
| Sexual Partners | 2 | 2019 | 804 | 0.060 |
Why?
|
| Alcohol Drinking | 1 | 2016 | 4040 | 0.050 |
Why?
|
| Guideline Adherence | 1 | 2013 | 2243 | 0.050 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2009 | 1971 | 0.050 |
Why?
|
| Safety | 1 | 2007 | 1157 | 0.050 |
Why?
|
| Colorado | 2 | 2013 | 167 | 0.050 |
Why?
|
| Vaccines, Conjugate | 1 | 2024 | 334 | 0.050 |
Why?
|
| Medicaid | 1 | 2015 | 2833 | 0.050 |
Why?
|
| Self Report | 1 | 2013 | 3770 | 0.050 |
Why?
|
| Connecticut | 2 | 2013 | 365 | 0.050 |
Why?
|
| Quality Improvement | 1 | 2016 | 3853 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 6069 | 0.050 |
Why?
|
| Immunization, Secondary | 1 | 2004 | 373 | 0.050 |
Why?
|
| Disease Outbreaks | 1 | 2010 | 1759 | 0.050 |
Why?
|
| Outpatients | 1 | 2009 | 1595 | 0.040 |
Why?
|
| New York | 2 | 2013 | 880 | 0.040 |
Why?
|
| Opioid-Related Disorders | 1 | 2015 | 2178 | 0.040 |
Why?
|
| Information Systems | 1 | 2022 | 400 | 0.040 |
Why?
|
| Seasons | 1 | 2006 | 1524 | 0.040 |
Why?
|
| Pneumococcal Vaccines | 1 | 2024 | 414 | 0.040 |
Why?
|
| Hydroxychloroquine | 1 | 2023 | 431 | 0.040 |
Why?
|
| Models, Statistical | 1 | 2014 | 5089 | 0.040 |
Why?
|
| Retrospective Studies | 5 | 2023 | 81514 | 0.040 |
Why?
|
| Demography | 2 | 2015 | 1641 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 15880 | 0.040 |
Why?
|
| Prescriptions | 1 | 2021 | 388 | 0.040 |
Why?
|
| Streptococcus pneumoniae | 1 | 2024 | 762 | 0.040 |
Why?
|
| Brazil | 1 | 2022 | 1248 | 0.040 |
Why?
|
| Aged, 80 and over | 4 | 2015 | 59489 | 0.040 |
Why?
|
| Research Design | 1 | 2012 | 6209 | 0.030 |
Why?
|
| Patient Compliance | 3 | 2001 | 2692 | 0.030 |
Why?
|
| Health Services Research | 1 | 2004 | 1808 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2013 | 14652 | 0.030 |
Why?
|
| Syphilis | 1 | 2018 | 243 | 0.030 |
Why?
|
| Kidney Failure, Chronic | 1 | 2008 | 2495 | 0.030 |
Why?
|
| Registries | 1 | 2011 | 8297 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2006 | 5302 | 0.030 |
Why?
|
| Capacity Building | 1 | 2016 | 266 | 0.030 |
Why?
|
| Gonorrhea | 1 | 2018 | 354 | 0.030 |
Why?
|
| Diabetes Mellitus | 1 | 2012 | 5891 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2007 | 3461 | 0.030 |
Why?
|
| Budgets | 1 | 2015 | 232 | 0.030 |
Why?
|
| Hepatitis B Antibodies | 1 | 2013 | 156 | 0.030 |
Why?
|
| Minnesota | 1 | 2013 | 336 | 0.030 |
Why?
|
| Time Factors | 3 | 2012 | 40065 | 0.020 |
Why?
|
| District of Columbia | 1 | 2012 | 159 | 0.020 |
Why?
|
| Eligibility Determination | 1 | 2015 | 423 | 0.020 |
Why?
|
| Clinical Coding | 1 | 2013 | 190 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2008 | 7425 | 0.020 |
Why?
|
| Death Certificates | 1 | 2012 | 170 | 0.020 |
Why?
|
| Oregon | 1 | 2011 | 148 | 0.020 |
Why?
|
| Rural Population | 1 | 2001 | 2317 | 0.020 |
Why?
|
| Hospitalization | 2 | 2013 | 10808 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2013 | 26318 | 0.020 |
Why?
|
| Injections | 1 | 2013 | 840 | 0.020 |
Why?
|
| Office Visits | 1 | 2014 | 595 | 0.020 |
Why?
|
| Anti-HIV Agents | 1 | 2024 | 4559 | 0.020 |
Why?
|
| Logistic Models | 2 | 2013 | 13266 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2013 | 2910 | 0.020 |
Why?
|
| Drug Costs | 1 | 2015 | 1193 | 0.020 |
Why?
|
| Recurrence | 1 | 2018 | 8501 | 0.020 |
Why?
|
| RNA, Viral | 1 | 2014 | 2864 | 0.020 |
Why?
|
| Diabetes Complications | 1 | 2012 | 1316 | 0.020 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2013 | 953 | 0.010 |
Why?
|
| Health Status Disparities | 1 | 2016 | 1880 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2001 | 20124 | 0.010 |
Why?
|
| Pandemics | 1 | 2023 | 8703 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2016 | 8733 | 0.010 |
Why?
|
| Health Policy | 1 | 2015 | 2698 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2024 | 41649 | 0.010 |
Why?
|
| Suburban Population | 1 | 2001 | 54 | 0.010 |
Why?
|
| Chickenpox Vaccine | 1 | 2001 | 39 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2007 | 2352 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2013 | 10070 | 0.010 |
Why?
|
| Risk Adjustment | 1 | 2004 | 596 | 0.010 |
Why?
|
| Genotype | 1 | 2015 | 13024 | 0.010 |
Why?
|
| Electronic Health Records | 1 | 2016 | 4873 | 0.010 |
Why?
|
| Forecasting | 1 | 2007 | 2936 | 0.010 |
Why?
|
| Maternal Age | 1 | 2001 | 804 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2013 | 22223 | 0.010 |
Why?
|
| Algorithms | 1 | 2013 | 14071 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2012 | 39193 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2007 | 24282 | 0.000 |
Why?
|
Concepts
(224)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(10)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_